韩正会见丹麦诺和诺德公司董事会主席

Core Viewpoint - The meeting between China's Vice President Han Zheng and Novo Nordisk's Chairman, Lars Fruergaard Jørgensen, highlights the strong economic complementarity and cooperation prospects between China and Denmark, particularly in the biopharmaceutical sector [1] Group 1: Economic Cooperation - Han Zheng emphasized the importance of enhancing mutual cooperation between China and Denmark, as well as within the broader China-Europe context, citing the strong economic complementarity [1] - The Chinese government is committed to deepening reforms and expanding high-level opening-up, which will provide significant growth opportunities for foreign companies, including Novo Nordisk [1] Group 2: Health and Investment - China prioritizes public health development, having established the world's largest basic medical insurance network, which continues to improve life expectancy [1] - Novo Nordisk expressed its intention to deepen its market presence in China and increase investments, aiming for mutual benefits [1]